我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
1
0 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
已完成
100.0%
暂无批准数据
- A human factors validation study showed that both adults and adolescents could successfully administer NaxSwab™ OTC in a simulated opioid overdose emergency. - The study included participants with varying literacy levels, demonstrating the usability of NaxSwab™ OTC across different demographics. - NaxSwab™ OTC exhibited faster naloxone absorption compared to intramuscular naloxone and naloxone spray in earlier pharmacokinetic studies. - Pocket Naloxone Corp. aims to make NaxSwab™ OTC affordable and accessible to combat opioid overdose deaths.